ADCT ADC Therapeutics SA
$1.59▲ +5.30%
Healthcare
Other
After hours
$1.59▲ +0.00%
Oct 27, 5:30 PM ET
Volume 1.25M
Avg Volume (10D) 1.31M
Key Metrics & Fundamentals
Market Cap
$202.99M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.78 - 4.98
% vs 50 MA
24.82%
% vs 200 MA
-36.73%
RSI-14
57.4
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.31
Free Cash Flow
-$11.81M
Gross Rev
$19.25M
Gross Profit
$16.90M
EBITDA
-$14.63M
COGS
$2.35M
Operating Exp
$39.68M
Operating Income
-$22.78M
EBIT
-$22.78M
Pretax Income
-$16.57M
Net Income
-$16.57M
EPS (Diluted)
-0.11
Price & Volume History
Loading chart…
Recent News
ADC Therapeutics Cuts Debt, Extends Runway Ahead of Key Drug Data, RBC Says
MT Newswires · Oct 9, 2026 11:27 AM ET
Sector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires · Oct 8, 2026 3:53 PM ET
Sector Update: Healthcare Stocks Decline in Afternoon Trading
MT Newswires · Oct 8, 2026 1:47 PM ET
ADC Therapeutics Shares Rise After Financial Restructuring Extends Cash Runway
MT Newswires · Oct 8, 2026 12:35 PM ET
ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
PR Newswire · Oct 8, 2026 9:00 AM ET
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
PR Newswire · Sep 3, 2026 7:15 AM ET
ADC Therapeutics (ADCT) Navigates FDA Setback While Cutting Its Losses
Insider Monkey · Aug 27, 2026 4:42 PM ET
ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 3:49 PM ET
ADC Therapeutics (ADCT) Stock Fair Value Falls After LOTIS 5 Reshapes Zynlonta Outlook
Simply Wall St. · Aug 15, 2026 11:15 PM ET
ADC Therapeutics Balances LOTIS-5 Regulatory Risk With LOTIS-7 Opportunity, RBC Says
MT Newswires · Aug 14, 2026 10:46 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ADCT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.